Sign in
ACUT Stock Price, Chart, Stats & News
Accustem Sciences Inc.
Save
Accustem Sciences Inc. (ACUT) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
ACUT chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer. Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer. The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers.
Similar securities
Based on sector and market capitalization
Report issue